A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following Resection
This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of
RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive,
surgically resected Stage II/III rectal cancer, or Stage II (high risk)/Stage III colon
Colorectal Cancer Stage II, Colorectal Cancer Stage III
RO7198457 intravenous (i.v.),
Observational group (no intervention)
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.